Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$107.58 USD
+3.31 (3.17%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $107.45 -0.13 (-0.12%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Brokerage Reports
Abbott Laboratories [ABT]
Reports for Purchase
Showing records 361 - 380 ( 527 total )
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
New US law, if implemented likely to impact Indian pharma exports to US and increase overall cost of drugs
Provider: FIRST GLOBAL
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Niche stents and aggressive business initiatives - measures to continue driving overall performance
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Industry Report ; MED PRODUCTS; This report contains brief updates on the following: ZBH, SYK, STJ, RHHBY, MDT, JNJ, GE, BSX, BDX, BAYRY, ABT. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: ZACKS INVESTMENT RESEARCH
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Niche stents and aggressive business initiatives - measures to drive overall performance..
Provider: FIRST GLOBAL
Analyst: THOMAS K